ADIPOQ and metabolic syndrome: Additionally, we found significant inverse correlation between adiponectin and ALT, a surrogate marker for nonalcoholic fatty liver disease, which has recently been considered as a predictor for development of type 2 diabetes and metabolic syndrome [17–19].